Finally, after so many months of suffering and uncertainty, since the beginning of November we had approximate date for vaccination against Covid-19. First, the American pharmaceutical Pfizer together with his German partner BionTech, were taking the lead to find a vaccine. Your vaccine has a 90% effective and consists of two doses of the drug. The company has announced that they have already made license applications for the drug and are waiting for it. In addition, they have also communicated that they expect supply 50 million doses before the end of this year, and 1.300 billion for next year.
A week later, the American pharmacist Modern announced that his vaccine was also ready and that he had a 94,5% Effectivenessbased on provisional data from your clinical trial. In this way, it became the second American company to confirm results that would far exceed expectations.
In the race are other laboratories who also have their project in phase 3, with thousands of people involved in the trial. According to the WHO registry, they stand out another ten prototypes in advanced stage, being the British vaccine of Oxford y AstraZeneca. They follow him A nephew (CH), WUHAN Institute of Biological Products (CH); Synopharm (CH); Beijing Institute of Biological Products (CH); CanSino Biological (CH); Gamaleya Research Institute (RUS); Janssen (USA); novavax (USA).
In so far this year the first impact news that we met was the project of Oxford / Astrazeneca. In October the company announced that by November they expected to have the vaccine with a similar immunity in young and old.